Explore a Type 1 Diabetes and Insulin Comparison Research Study
Type 1 Diabetes is a chronic autoimmune condition where the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. As a result, the body is no longer able to produce insulin, a hormone critical for regulating blood sugar levels. Individuals with Type 1 Diabetes must rely on daily insulin therapy for survival. Without insulin, glucose cannot enter the body’s cells to be used for energy, causing high blood sugar levels that can lead to serious long-term complications such as kidney failure, nerve damage, vision loss, and heart disease
Although insulin therapy is lifesaving, managing Type 1 Diabetes through multiple daily injections can be complex, intrusive, and emotionally taxing. Many people face challenges in maintaining consistent blood sugar levels despite their best efforts.
Prime Revival Research Institute is now enrolling participants in a type 1 diabetes clinical trial in Texas. This clinical study is designed to evaluate the safety and effectiveness of a once-weekly insulin compared to a standard once-daily insulin injection. Both are used alongside mealtime insulin to help participants maintain better blood glucose control. The aim is to assess whether the investigational insulin provides equal or improved glycemic outcomes while reducing the number of required injections each week.
You may qualify to participate if you:
- Are 18 years of age or older (male or female)
- Have been diagnosed with type 1 diabetes for at least 1 year
- Are currently on a multiple daily insulin injection regimen
- Have an HbA1c between 7.0% and 10.0%
*Additional criteria may apply.
Your doctor will go over the additional study criteria with you to determine if you qualify. If you qualify and decide to participate in the type 1 diabetes clinical trials in Texas, you will receive all study-related care, free of cost.
*You will be compensated for your time and travel expenses.
*If you think you may be eligible to participate in the paid type 1 diabetes and insulin comparison research studies or would like more information, please enter your information in the form so our research team can determine if you qualify and could contact you about the study.
About The Sleep Apnea and Obesity Clinical Trials
Prime Revival Research Institute is conducting insulin-dependent diabetes research study that focuses on evaluating a once-weekly insulin and comparing it to a standard once-daily insulin. Both will be used in combination with mealtime insulin to mealtime glucose control.
The purpose of the type 1 diabetes clinical trial is to understand whether once-weekly insulin treatment can deliver the same or better glycemic control as traditional therapy. This insulin treatment comparison study could provide an important breakthrough in managing insulin-dependent diabetes.
If you qualify and choose to participate, you will be randomly assigned to receive either the investigational insulin or the standard insulin treatment. Participants will attend scheduled clinic visits to monitor their blood sugar levels, overall health, and medication response.
About Type 1 Diabetes and Insulin Therapy
Type 1 Diabetes (T1D) occurs when the immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas. Without insulin, the body is unable to regulate glucose levels in the bloodstream, leading to hyperglycemia and potentially life-threatening complications if left untreated. Unlike Type 2 Diabetes, which can sometimes be managed with lifestyle changes and oral medications, T1D requires lifelong insulin therapy from the point of diagnosis.
Insulin therapy plays a vital role in helping individuals with T1D manage their blood sugar levels and prevent acute complications such as diabetic ketoacidosis (DKA) and chronic issues like nerve damage, kidney disease, and vision loss. Most people with T1D rely on multiple daily injections (MDI) or insulin pumps, which can be disruptive, time-consuming, and stressful to maintain. Through this insulin-dependent diabetes research, the goal is to bring patients one step closer to a more manageable routine, reduce treatment fatigue, and help improve overall quality of life for those who face the demands of T1D every day.
RECRUITINGSTATUS AND CRITERIA
$ 99
Per Month- Age 18 years or older
- Gender Male or female
- Condition Type 1 Diabetes
- Location Texas
What to Expect?
If you would like to learn more about our type 1 diabetes clinical trials, please fill out the form above. A research representative will contact you to provide more information about the study. If you qualify for the type 1 diabetes clinical trials, you will be invited to our study site for screening. If you qualify after the screenings and choose to participate, you will be asked to sign an informed consent form outlining the criteria and details of the investigational study treatment.
After signing, you may be asked to answer health-related questions and undergo various assessments and tests to determine your eligibility as a clinical trial participant. During the study, participants will be randomly assigned to get either investigational medicine or placebo.
*Participants will receive free-of-cost investigational treatment. If you choose to join our type 1 diabetes clinical trials in Texas, you may also receive study-related care from healthcare professionals.
Frequently Asked Questions (FAQs)
What is this type 1 diabetes clinical trial about?
This study compares a once-weekly insulin with a standard once-daily insulin, both taken alongside mealtime insulin. It aims to determine whether the investigational treatment is as effective or better at managing blood sugar levels.
Will I need to stop taking my current insulin?
Participants will transition from their current insulin regimen to the study treatment. Your study doctor will closely monitor this transition to ensure safety and proper blood sugar management.
Can I withdraw from the study at any time?
Yes, participation is entirely voluntary. You can withdraw at any point for any reason without affecting your regular medical care or relationship with the study team.
What are the common symptoms of Type 1 Diabetes?
Common symptoms of Type 1 Diabetes include:
- Frequent urination
- Extreme thirst
- Increased hunger
- Unintended weight loss
- Fatigue
- Blurred vision
- Irritability
- Slow-healing wounds
How is this different from standard insulin treatment?
This type 1 diabetes and insulin comparison research study examines whether a once-weekly insulin option can offer similar or better results compared to daily injections, potentially making diabetes management more convenient.